Skip to content
healthcare.dev

LOTRONEX

NDC 54766-895, alosetron hydrochloride, tablet, from Sebela Pharmaceuticals Inc..

Product NDC
54766-895
Status
Listed
Labeler
Sebela Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021107
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/54766-895 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALOSETRON HYDROCHLORIDE1 mg/1

Pharmacologic classes

Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]

Package NDCNDC-11Package
54766-895-035476608950330 TABLET in 1 BOTTLE (54766-895-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/35cbb9d5-639b-207a-e054-00144ff88e88

Use it

Look up 54766-895 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/54766-895 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 54766-895. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.